COVID Intel - by William Makis (McGill Medicine)

COVID Intel - by William Makis (McGill Medicine)

Thymoquinone (Black Seed Oil / Nigella Sativa) and CANCER - New Research - 5 papers reviewed

William Makis's avatar
William Makis
Apr 29, 2024
∙ Paid
Black Seed Oil: Benefits, Uses, Side Effects, and More

Papers Reviewed:

  • 2021 April, Almajali et al - Thymoquinone, as a Novel Therapeutic Candidate of Cancers

  • 2023 Sep, Das et al - A mechanistic insight into the potential anti-cancerous property of Nigella sativa on breast cancer through micro-RNA regulation: An in vitro & in vivo study

  • 2023 Jan, Zhao et al - Advances in research on the relationship between thymoquinone and pancreatic cancer

  • 2023 Dec, Sheikhnia et al - Potential anticancer properties and mechanisms of thymoquinone in colorectal cancer

  • 2023 Aug, Osorio-Perez et al - Thymoquinone Potentially Modulates the Expression of Key Onco- and Tumor Suppressor miRNAs in Prostate and Colon Cancer Cell Lines: Insights from PC3 and HCT-15 Cells

======

2021 April, Almajali et al - Thymoquinone, as a Novel Therapeutic Candidate of Cancers

  • Thymoquinone (TQ) is one of the bioactive constituents in Nigella sativa (N. sativa), black seed

Keep reading with a 7-day free trial

Subscribe to COVID Intel - by William Makis (McGill Medicine) to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 William Makis
Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture